211 related articles for article (PubMed ID: 32752092)
1. The Role of Pre-Clinical 3-Dimensional Models of Osteosarcoma.
Smith HL; Beers SA; Gray JC; Kanczler JM
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752092
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma.
Kunz P; Schenker A; Sähr H; Lehner B; Fellenberg J
PLoS One; 2019; 14(4):e0215312. PubMed ID: 30986223
[TBL] [Abstract][Full Text] [Related]
3. Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche.
Bassi G; Panseri S; Dozio SM; Sandri M; Campodoni E; Dapporto M; Sprio S; Tampieri A; Montesi M
Sci Rep; 2020 Dec; 10(1):22294. PubMed ID: 33339857
[TBL] [Abstract][Full Text] [Related]
4. Non-rodent animal models of osteosarcoma: A review.
Jarvis S; Koumadoraki E; Madouros N; Sharif S; Saleem A; Khan S
Cancer Treat Res Commun; 2021; 27():100307. PubMed ID: 33453605
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma, personalized medicine, and tissue engineering; an overview of overlapping fields of research.
Bozorgi A; Sabouri L
Cancer Treat Res Commun; 2021; 27():100324. PubMed ID: 33517237
[TBL] [Abstract][Full Text] [Related]
6. Extended analysis of intratumoral heterogeneity of primary osteosarcoma tissue using 3D-in-vivo-tumor-model.
Feder AL; Pion E; Troebs J; Lenze U; Prantl L; Htwe MM; Phyo A; Haerteis S; Aung T
Clin Hemorheol Microcirc; 2020; 76(2):133-141. PubMed ID: 32925008
[TBL] [Abstract][Full Text] [Related]
7. From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma.
Dean DC; Shen S; Hornicek FJ; Duan Z
Cancer Metastasis Rev; 2018 Dec; 37(4):719-731. PubMed ID: 30167827
[TBL] [Abstract][Full Text] [Related]
8. A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma.
Wagner F; Holzapfel BM; Martine LC; McGovern J; Lahr CA; Boxberg M; Prodinger PM; Grässel S; Loessner D; Hutmacher DW
Acta Biomater; 2019 Apr; 89():372-381. PubMed ID: 30836200
[TBL] [Abstract][Full Text] [Related]
9. Morphological characterization of a newly established human osteosarcoma cell line, HS-Os-1, revealing its distinct osteoblastic nature.
Sonobe H; Mizobuchi H; Manabe Y; Furihata M; Iwata J; Hikita T; Oka T; Ohtsuki Y; Goto T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(3):181-7. PubMed ID: 1679269
[TBL] [Abstract][Full Text] [Related]
10. Relevance of 3d culture systems to study osteosarcoma environment.
De Luca A; Raimondi L; Salamanna F; Carina V; Costa V; Bellavia D; Alessandro R; Fini M; Giavaresi G
J Exp Clin Cancer Res; 2018 Jan; 37(1):2. PubMed ID: 29304852
[TBL] [Abstract][Full Text] [Related]
11. Singe nucleotide polymorphisms in osteosarcoma: Pathogenic effect and prognostic significance.
Asnafi AA; Behzad MM; Ghanavat M; Shahjahani M; Saki N
Exp Mol Pathol; 2019 Feb; 106():63-77. PubMed ID: 30528563
[TBL] [Abstract][Full Text] [Related]
12. Gold Nanoparticles Inhibit Extravasation of Canine Osteosarcoma Cells in the Ex Ovo Chicken Embryo Chorioallantoic Membrane Model.
Małek A; Wojnicki M; Borkowska A; Wójcik M; Ziółek G; Lechowski R; Zabielska-Koczywąs K
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373007
[TBL] [Abstract][Full Text] [Related]
13. A comparison between genetic portraits of normal osteoblasts and osteosarcoma cell lines.
Palmieri A; Pezzetti F; Brunelli G; Ilaria Z; Carinci F
Indian J Dent Res; 2009; 20(1):52-9. PubMed ID: 19336861
[TBL] [Abstract][Full Text] [Related]
14. Creating
Chow T; Wutami I; Lucarelli E; Choong PF; Duchi S; Di Bella C
Tissue Eng Part B Rev; 2021 Oct; 27(5):514-529. PubMed ID: 33138724
[TBL] [Abstract][Full Text] [Related]
15. Osteosarcoma in the Post Genome Era: Preclinical Models and Approaches to Identify Tractable Therapeutic Targets.
Castillo-Tandazo W; Mutsaers AJ; Walkley CR
Curr Osteoporos Rep; 2019 Oct; 17(5):343-352. PubMed ID: 31529263
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs.
Chen C; Xie L; Ren T; Huang Y; Xu J; Guo W
Cancer Lett; 2021 Mar; 500():1-10. PubMed ID: 33359211
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
[TBL] [Abstract][Full Text] [Related]
18. Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma.
Scott MC; Temiz NA; Sarver AE; LaRue RS; Rathe SK; Varshney J; Wolf NK; Moriarity BS; O'Brien TD; Spector LG; Largaespada DA; Modiano JF; Subramanian S; Sarver AL
Cancer Res; 2018 Jan; 78(2):326-337. PubMed ID: 29066513
[TBL] [Abstract][Full Text] [Related]
19. Lung cells support osteosarcoma cell migration and survival.
Yu S; Fourman MS; Mahjoub A; Mandell JB; Crasto JA; Greco NG; Weiss KR
BMC Cancer; 2017 Jan; 17(1):78. PubMed ID: 28122543
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs for osteosarcoma in the mouse: a meta-analysis.
Chang J; Yao M; Li Y; Zhao D; Hu S; Cui X; Liu G; Shi Q; Wang Y; Yang Y
Oncotarget; 2016 Dec; 7(51):85650-85674. PubMed ID: 27852052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
